Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training
NCT ID: NCT00431223
Last Updated: 2020-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2006-09-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Skills Training Using Computer for Patients With Severe Mental Illness
NCT01036282
Functional Neuroimaging Effects of Cognitive Remediation Training
NCT00481156
Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia
NCT03621540
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
NCT01988714
Can Cognitive Training Decrease Reactive Aggression?
NCT03623477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After screening, patients are randomized to a 12 week trial of CRT using COGPACK (Marker Software), or to a 12-week control condition. All patients attend 3 weekly 1-hour laboratory sessions, with 1 discussion session per week.
Patients continue their antipsychotic treatment with a typical or atypical antipsychotic during the CRT and 4 weeks prior to enrollment in the study (Phase A). Following Phase A they receive baseline evaluations, including an cognitive activation task (N-back visual-letter task) while being scanned for fMRI , MATRICS neuropsychological test battery, and psychiatric, social functioning, and symptoms assessment.
Patients then enter Phase B with randomization to control or CRT for 12 weeks (36 laboratory sessions). Upon successful completion of 36 sessions, endpoint evaluations include an N-back task while fMRI scan, MATRICS, psychiatric, and social functional assessments.
All baseline and endpoint fMRI scans are conducted at the Center for Advanced Brain Imaging (CABI) at Nathan Kline Institute for Psychiatric Research.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Group
7 patients were assigned to Cognitive Remediation Therapy..
Cognitive remediation therapy
36 sessions of computerized cognitive skills training over a 12 week duration. 7 patients were assigned to cognitive remediation therapy or CRT Group.
Control Group
4 patients were assigned to Control group or no cognitive remediation therapy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive remediation therapy
36 sessions of computerized cognitive skills training over a 12 week duration. 7 patients were assigned to cognitive remediation therapy or CRT Group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 55
* Male gender (females are enrolled but will not be scanned)
* DSM-IV diagnosis of schizophrenia (all subtypes) and schizoaffective disorder
* illness duration \> 5 years
* MMSE score \> 24 (inclusive) at screening
* Stable dose of oral atypical antipsychotic for at least 4 weeks prior to study entry
* Total PANSS score \> 60 at screening
* Capacity and willingness to give written informed consent
* Patients deemed not ready to be discharged within the next 12 weeks
Exclusion Criteria
* Documented disease of the central nervous system
* History of intellectual impairment pre-dating onset of symptoms of psychosis (e.g. mental retardation)
* Clinically significant or unstable cardiovascular, renal, hepatic, gastrointestinal, pulmonary, or hematological conditions; HIV positive
* Any medical condition rendering the subject unable to receive an fMRI scan
18 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nathan Kline Institute for Psychiatric Research
OTHER
Manhattan Psychiatric Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean-Pierre Lindenmayer
Clinical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saurabh Kaushik, MD
Role: PRINCIPAL_INVESTIGATOR
Manhattan Psychaitric Center
Jean-Pierre Lindenmayer, MD
Role: STUDY_CHAIR
Manhattan Psychiatric Center
Susan McGurk, PhD
Role: STUDY_CHAIR
Dartmouth College, Hanover
Craig A. Branch, PhD
Role: STUDY_CHAIR
Center for Advanced Brain Imaging, NKI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manhattan Psychiatric Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull. 1999;25(2):291-307. doi: 10.1093/oxfordjournals.schbul.a033379.
Related Links
Access external resources that provide additional context or updates about the study.
FMRIB Software Library
Wikipedia entry for fMRI
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05I/C52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.